This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Innovations of Alexandra S Gambaryan
Introduction
Alexandra S Gambaryan is a notable inventor based in Moscow, Russia. She has made significant contributions to the field of virology through her innovative research and development of viral attachment inhibitors. Her work focuses on creating novel compounds that can effectively inhibit viral attachment to target cells.
Latest Patents
One of her key patents involves the use of neuraminic acid compounds to inhibit viral attachment. The patent describes a formula where R.sup.1 is selected from hydrogen and acetyl, R.sup.2 is selected from hydrogen and methyl, and Y is selected from specific groups. These novel compounds bind to virus particles and are substantially uncleaved by neuraminidase. Additionally, coupling these compounds to a polymer further enhances their ability to inhibit viral attachment. This patent showcases her innovative approach to combating viral infections.
Career Highlights
Throughout her career, Alexandra has demonstrated a strong commitment to advancing scientific knowledge in her field. Her research has led to the development of effective antiviral strategies, contributing to public health initiatives. She has been recognized for her work and continues to be an influential figure in virology.
Collaborations
Alexandra has collaborated with esteemed colleagues, including Nicolai Vladimirovich Bovin and Nargiz E Bryamova. These partnerships have fostered a collaborative environment that enhances the quality and impact of her research.
Conclusion
Alexandra S Gambaryan's innovative work in developing viral attachment inhibitors highlights her significant contributions to virology. Her research not only advances scientific understanding but also has the potential to improve therapeutic strategies against viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile